The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors

Oncogene

Volumn 21, Issue 54, 2002, Pages 8302-8309

  Nishimori, Hiroyuki ^a   Sasaki, Yasushi ^a   Yoshida, Koichi ^a   Irifune, Hideto ^a   Zembutsu, Hitoshi ^b   Tanaka, Toshihiro ^b   Aoyama, Tomoki ^c,d   Hosaka, Taisuke ^c,d   Kawaguchi, Satoshi ^a   Wada, Takuro ^a   Hata, Jun Ichi ^e   Toguchida, Junya ^c   Nakamura, Yusuke ^b   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ewing family tumor; EWS ETS; Id2

Indexed keywords

COMPLEMENTARY DNA; DNA; HYBRID PROTEIN; LUCIFERASE; RETROVIRUS VECTOR;

ARTICLE; CELL DIFFERENTIATION; DNA BINDING; DNA MICROARRAY; EWING SARCOMA; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ID2 GENE; IMMUNOBLOTTING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; TRANSCRIPTION INITIATION; VIRUS INFECTION;

UNIDENTIFIED RETROVIRUS;

EID: 18744410355     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206025     Document Type: Article

References (38)

1. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV and Denny CT. (1998). Oncogene, 17, 2039-2045.
2. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell. Biol., 14, 3230-3241.
3. Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE and Delattre O. (2001). Oncogene, 20, 3258-3265.
4. de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindan FJ, Healey JH and Ladanyi M. (2000). Cancer, 89, 783-792.
5. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Heinrich K, Houbert I, de Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
6. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A and Thomas G. (1994). New Engl. J. Med., 31, 294-299.
7. Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS and Evans GA. (1994). J. Clin. Invest., 94, 489-496.
8. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ and Kim SJ. (1999). Nature Genet., 23, 222-227.
9. Ishida S, Yamashita T, Nakaya U and Tokino T. (2000). Jpn. J. Cancer Res., 91, 174-180.
10. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT and Shapiro DN. (1995). Oncogene, 10, 1229-1234.
11. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira Y, Tanaka Y, Sasaki Y, Ishida S, Higashino F and Fujinaga K. (1996). Genes Chromosomes Cancer, 15, 115-121.
12. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, Kitahara O, Zembutsu H, Yanagawa R, Hirata K, Takagi I and Nakamura Y. (2001). Cancer Res., 61, 6474-6479.
13. Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA and Korc M. (1998). Cancer Res., 58, 3769-3772.
14. Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, Thomas G and Gadner H. (1996). Cell Growth Differ., 7, 429-437.
15. Lasorella A, Noseda M, Beyna M, Yokota Y and Iavarone A. (2000). Nature, 407, 592-598.
16. Lasorella A, Uo T and Iavarone A. (2001). Oncogene, 20, 8326-8333.
17. Lopez-Guerrero JA, Pellin A, Noguera R, Carda C and Llombart-Bosch A. (2001). Lab. Invest., 81, 803-814.
18. Mao X, Miesfeldt S, Yang H, Leiden JM and Thompson CB. (1994). J. Biol. Chem., 27, 18216-18222.
19. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G and Denny CT. (1993a). Proc. Natl. Acad. Sci. USA, 90, 5752-5756.
20. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT. (1993b). Mol. Cell. Biol., 13, 7393-7398.
21. May WA, Arvand A, Thompson AD, Braun BS, Wright M and Denny CT. (1997). Nature Genet., 17, 495-497.
22. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 3587-3596.
23. Morimoto I, Sasaki Y, Ishida S, Imai K and Tokino T. (2002). Genes Chromosomes Cancer, 33, 270-278.
24. Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T and Nakamura Y. (2000). Cancer Res., 60, 5007-5011.
25. Ouchida M, Ohno T, Fujimura Y, Rao VN and Reddy ES. (1995). Oncogene, 11, 1049-1054.
26. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H and Delattre O. (1997). Oncogene, 14, 1159-1164.
27. Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ and Phillips WA. (2001). J. Biol. Chem., 276, 45113-45119.
28. Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y and Tokino T. (2002). J. Biol. Chem., 277, 719-724.
29. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT. (1994). Nature Genet., 6, 146-151.
30. Tanaka K, Iwakuma T, Harimaya K, Sato H and Iwamoto Y. (1997). J. Clin. Invest., 99, 239-247.
31. Thompson AD, Braun SB, Arvand A, Stewart SD, May WA, Chen E, Korenberg J and Denny CT. (1996). Oncogene, 13, 2649-2658.
32. Urano F, Umezawa A, Hong Y, Kikuchi H and Hata JI. (1996). Biochem. Biophys. Res. Commun., 219, 608-612.
33. Urano F, Umezawa A, Yabe H, Hong W, Yoshida K, Fujinaga K and Hata J. (1998). Jpn. J. Cancer Res., 89, 703-711.
34. Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH and Ladanyi M. (2000). Cancer, 89, 783-789.
35. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S and Gruss P. (1999). Nature, 397, 702-706.
36. Yokota Y. (2001). Oncogene, 20, 8290-8298.
37. Zebedee Z and Hara E. (2001). Oncogene, 20, 8317-8325.
38. Zwerner JP and May WA. (2001). Oncogene, 20, 626-633.